+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novavax Inc - logo

Novavax is a clinical-stage vaccine company that develops recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization, seasonal quadrivalent influenza and pandemic H7N9 vaccines, a vaccine candidate against Ebola Virus and others. Founded in 1987, it is headquartered in Gaithersburg, Maryland.

The World Market for Vaccines, 2024 - Product Thumbnail Image

The World Market for Vaccines, 2024

  • Report
  • February 2024
  • 202 Pages
  • Global
From
From
From
SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026 - Product Thumbnail Image

SARS-CoV-2 COVID Vaccine Market Analysis & Forecast to 2026

  • Report
  • March 2021
  • 137 Pages
  • Global
From
From
From
From
From
Covid-19 Vaccination Market 2024-2028 - Product Thumbnail Image

Covid-19 Vaccination Market 2024-2028

  • Report
  • September 2024
  • 173 Pages
  • Global
From
Vaccine Research Market 2024-2028 - Product Thumbnail Image

Vaccine Research Market 2024-2028

  • Report
  • August 2024
  • 170 Pages
  • Global
From
Influenza Vaccine Market 2024-2028 - Product Thumbnail Image

Influenza Vaccine Market 2024-2028

  • Report
  • August 2024
  • 168 Pages
  • Global
From
Vaccines Market 2024-2028 - Product Thumbnail Image

Vaccines Market 2024-2028

  • Report
  • March 2024
  • 163 Pages
  • Global
From
From
Influenza Vaccines: Global Markets - Product Thumbnail Image

Influenza Vaccines: Global Markets

  • Report
  • May 2022
  • 109 Pages
  • Global
From
Loading Indicator